BEGIN:VCALENDAR VERSION:2.0 PRODID:-//pretalx//sciencenext.org//ifos2026//JUTYS3 BEGIN:VTIMEZONE TZID:EET BEGIN:STANDARD DTSTART:20001029T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z TZNAME:EET TZOFFSETFROM:+0300 TZOFFSETTO:+0200 END:STANDARD BEGIN:STANDARD DTSTART:20071028T050000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z TZNAME:EET TZOFFSETFROM:+0300 TZOFFSETTO:+0200 END:STANDARD BEGIN:STANDARD DTSTART:20151108T050000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z TZNAME:EET TZOFFSETFROM:+0300 TZOFFSETTO:+0200 END:STANDARD BEGIN:STANDARD DTSTART:20160907T010000 RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9 TZNAME:+03 TZOFFSETFROM:+0300 TZOFFSETTO:+0300 END:STANDARD BEGIN:DAYLIGHT DTSTART:20000326T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20070325T040000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20110328T040000 RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20120325T040000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20140331T040000 RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20150329T040000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z TZNAME:EEST TZOFFSETFROM:+0200 TZOFFSETTO:+0300 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:pretalx-ifos2026-AEJQ3N@sciencenext.org DTSTART;TZID=EET:20260911T153000 DTEND;TZID=EET:20260911T160000 DESCRIPTION:

Com ponent-resolved diagnosis (CRD) has emerged as a valuable complement to co nventional allergy testing by identifying specific allergenic molecules ra ther than whole allergen extracts. For otorhinolaryngologists managing pat ients with allergic rhinitis\, polysensitization\, oral allergy syndrome\, or uncertain clinical–test correlations\, CRD can provide a more precis e understanding of the patient’s sensitization profile.

This instructional course w ill introduce the basic principles of molecular allergology and demonstrat e how CRD can be incorporated into everyday rhinology practice. Particular emphasis will be placed on distinguishing genuine primary sensitization f rom cross-reactivity\, recognizing major allergen components and panallerg ens\, and interpreting sensitization to profilins\, polcalcins\, lipid tra nsfer proteins\, tropomyosins\, and cross-reactive carbohydrate determinan ts. Clinically relevant examples involving grass\, tree and weed pollens\, house dust mites\, moulds\, and selected food allergens will be discussed .

Participa nts will learn how molecular findings may clarify apparently conflicting s kin-prick test or specific IgE results\, identify the allergen sources mos t likely to be responsible for symptoms\, and improve the selection of all ergens for allergen immunotherapy. The course will also address the limita tions of CRD\, including the distinction between sensitization and clinica lly relevant allergy\, the need to interpret results within the context of exposure and symptom history\, and situations in which molecular testing is unlikely to alter management.

Through case-based discussions\, the course aims to provide otorhinolaryngologists with a practical framework for requesting\, interpreting\, and applying CRD appropriately. At the end of the session\ , participants should be able to use molecular allergy testing more confid ently while avoiding both overdiagnosis and unnecessary allergen immunothe rapy.

DTSTAMP:20260805T060706Z LOCATION:Rhinology 5 + Allergy (ICC - B2 level YILDIZ 1) SUMMARY:Component-Resolved Diagnosis for Otorhinolaryngologists - Müge Öz can\, Nurcan Yurtsever Kum URL:https://sciencenext.org/ifos2026/talk/AEJQ3N/ END:VEVENT END:VCALENDAR